Kristen Coppock, MA, Editor

The 2018-19 Best Hospital’s Honor Roll is a distinction awarded to 20 hospitals delivering exceptional treatment across multiple areas of care.

The Mayo Clinic in Rochester, Minnesota, is at the top of the Best Hospitals ranking by U.S. News & World Report, and is included in the Top 5 lists for 3 selected specialties.

The FDA has permitted marketing of Natural Cycles, the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

The FDA has approved several strengths of Apotex Inc.’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation

The FDA has approved several strengths of Apotex Inc.’s potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy designation.

The agency has amended its list of drugs that contain the ingredient, which is used to treat high blood pressure and heart failure.

The FDA is encouraging the development of novel medication-assisted treatment drugs for individuals with opioid use disorder (OUD), while the first non-opioid medication indicated for the reduction of opioid withdrawal symptoms has been made available to the market.

The FDA is warning consumers against serious risks of some ‘vaginal rejuvenation’ devices, and a lack of evidence to support their uses for this purpose.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Officials with the FDA have approved elagolix (Orilissa, AbbVie), a product specifically developed for women with moderate to severe endometriosis pain.

Officials with the FDA have approved elagolix (Orilissa, AbbVie), a product specifically developed for women with moderate to severe endometriosis pain.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

The FDA has approved AbbVie's elagolix (Orilissa) product, a drug specifically developed for women with moderate to severe endometriosis pain.

Student pharmacists at 2 universities in vastly different communities will learn how the other half practices pharmacy during a new program that will send each group across the country.

Pharmacists will provide first aid and over-the-counter treatments along the RAGBRAI route, which stretches more than 400 miles across Iowa.

Thousands of pharmacists were polled for their over-the-counter recommendations in a variety of categories. The picks showed that although they aren’t all in agreement, pharmacists do have some clear favorites when it comes to OTC products for treating coughs, colds, and seasonal allergies.

REMOXY ER is an abuse-deterrent, oral formulation of the widely prescribed opioid medication oxycodone.

The FDA voted against recommendign oxycodone extended-release capsules (REMOXY ER, Pain Therapeutics) for approval for the management of pain severe enough to require long-term, around-the-clock opioid treatment, during a joint meeting of the agency’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), and the Drug Safety and Risk Management Advisory Committee (DSARM).

The top prizes in the global Ascenia Diabetes Challenge were announced Friday at the American Diabetes Association’s 78th Annual Scientific Sessions in Orlando, Florida.

An improvement in clinical outcomes and medication adherence rates when patients used medication therapy management services and multimed blister card packaging was clearly shown in a recent study.